@article{article_591439, title={Immunosuppressive Patient Problem in Probiotic Use: Saccharomyces boulardii fungemia in a patient receiving cancer chemotherapy: Case Report}, journal={Black Sea Journal of Health Science}, volume={3}, pages={14–17}, year={2020}, author={Alkan Çeviker, Sevil and Yıldırım, Harun and Yıldız, Emel}, keywords={Saccharomyces boulardii,Probiotic,Fungemia}, abstract={<p class="MsoNormal" style="line-height:150%;"> <font face="Times New Roman, serif"> <span style="font-size:16px;">Probiotics are generally prescribed as an adjuvant in the treatment of antibiotic-associated diarrhea caused by Clostridium difficile and are considered a safe preparation. Recently, however, there have been reports in the literature about fungemia that develop after probiotic treatment, especially in immunosuppressive patients. In this article, we aimed to present a patient who received chemotherapy for gastric cancer, developed fungemia after Saccharomyces boulardii probiotic treatment and required intensive care. </span> </font> <br /> </p> <p> </p>}, number={1}, publisher={Karyay Karadeniz Yayımcılık Ve Organizasyon Ticaret Limited Şirketi}